Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers Meeting Abstract


Authors: Gautschi, O.; Subbiah, V.; Konda, B.; Bauer, T.; McCoach, C.; Falchook, G.; Takeda, M.; Patel, J.; Weiss, J.; Peled, N.; Bazhenova, L.; Soldatenkova, V.; French, P.; Drove, N.; Drilon, A.
Abstract Title: Efficacy and safety of selpercatinib in RET fusion-positive cancers other than lung or thyroid cancers
Meeting Title: Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie (Hybrid-Kongress)
Journal Title: Oncology Research and Treatment
Volume: 44
Issue: Suppl. 2
Meeting Dates: 2021 Oct 01-04
Meeting Location: Berlin, Germany
ISSN: 2296-5270
Publisher: S. Karger AG  
Date Published: 2021-09-01
Start Page: 12
Language: English
ACCESSION: WOS:000760622600025
PROVIDER: wos
DOI: 10.1159/000518417
Notes: Meeting Abstract: V184 -- Meeting was also presented virtually -- "Joint Annual Meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology (Hybrid Congress)" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon
Related MSK Work